PHARMACEUTICAL COMPOUNDS

A compound which is an arylimidazolyl isoxazole of formula (I): (Formula (I)) or a pharmaceutically acceptable salt thereof. The compound has activity in modulating the activity of p300 and/or CBP and is used to treat cancer, particularly prostate cancer.

Saved in:
Bibliographic Details
Main Authors PAOLETTA, Silvia, TADDEI, David Michel Adrien, PEGG, Neil Anthony, ONIONS, Stuart Thomas, SHANNON, Jonathan, BROWN, Richard James, HARBOTTLE, Gareth, SMYTH, Don
Format Patent
LanguageEnglish
Published 26.10.2022
Online AccessGet full text

Cover

More Information
Summary:A compound which is an arylimidazolyl isoxazole of formula (I): (Formula (I)) or a pharmaceutically acceptable salt thereof. The compound has activity in modulating the activity of p300 and/or CBP and is used to treat cancer, particularly prostate cancer.
Bibliography:Application Number: ZA20190002334